Key Dates
- June 28, 2022 - Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional). See NOFO RFA-AR-23-001.
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD )
The National Institute of Neurological Disorders and Stroke (NINDS) , with other NIH Institutes and Centers (ICs) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) , intends to promote an initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities in the patient and advocacy communities and to incorporate community perspectives into the conduct of patient-centered research.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The NOFO is expected to be published in Summer 2023 with an expected application due date in Fall 2023 .
This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.
This Notice encourages investigators with expertise and insights into basic and clinical muscular dystrophy research to begin to consider applying for this NOFO.
In addition, collaborative investigations combining expertise in physiology, cardiology, pulmonology, neurology, bioinformatics, bioengineering or other relevant fields will be encouraged, and these investigators should also begin considering applying for this application.
Among the areas of research encouraged in this initiative are patient-oriented and synergistic pre-clinical research examining the mechanisms that underlie the effects of muscular dystrophies as well as research designed to improve the translation of existing knowledge of strategies for the prevention and treatment of muscular dystrophies.
Funding Information
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
NIH intends to commit a total of $3,200,000, for fiscal year 2024. Future year amounts will depend on annual appropriations.
The participating NIH institutes expect to fund a total of two Centers through this NOFO.
Applicants may request up to $1,000,000 direct costs/year (exclusive of facilities and administrative costs of subcontractors with collaborating organizations) for up to four years
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Eligible Agencies of the Federal Government
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Glen H. Nuckolls, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5876
Email: glen.nuckolls@nih.gov
and Human Services (HHS)
